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Abstract
Objectives: 1) to assess the prevalence of hepatitis C virus (HCV) infection in a population of
acute psychiatric in-patients; 2) to find out relationships between HCV comorbidity and clinical
features of psychiatric patients.
Methods: Prospective observational study in a 6-year period.
Results: 2396 cases (1492 patients) were admitted in the considered period. Forty-two patients
(2.8%) were affected by HCV infection. HCV infection was more frequent in patients with less years
of education, lower social class, lower last year best Global Assessment of Functioning score, more
hostile or violent behavior in hospital, with a lifetime history of previous suicide attempt, and with
substance-related disorders.
Conclusion: HCV infection in psychiatric patients constitutes a major threat to the health of
psychiatric patients and is related with unfavorable social background, worse global functioning,
hostile or violent behavior, substance-related disorders. It appears also to be a significant risk of
suicidal behavior.
Background
Patients with comorbid conditions probably represent
majority of subjects affected by mood disorders or schizo-
phrenia [1]. Comorbid medical diseases may cause or
worsen psychiatric disorders and have a major impact on
the medical treatment of patients [2-4]. Nearly 50% of
medical comorbid diseases are not diagnosed in chronic
psychiatric outpatients [5]. Also in psychiatric in-patients,
medical diseases are often not diagnosed [6]. Psychosis
may impair the patient's capacity to recognize or describe
emerging medical illness. Consequently, psychiatric
patients often receive inadequate care [1]. Numerous
studies have demonstrated mortality rates that are at least
twice as high among persons with severe mental illness,
with a life expectancy ten years less than that of the gen-
eral population. Some authors have attributed these poor
health outcomes to clients' lack of regular medical care [7-
12].
Hepatitis C is a silent disease, with symptoms developing
an average of 20 years after infection. Around 85% of per-
sons infected with hepatitis C develop lifelong chronic
infection. Approximately 20% of chronically infected per-
sons will develop cirrhosis, and approximately 3% will
develop hepatocellular carcinoma [13]. Hepatitis C is the
most common chronic blood-borne infection in Italy as
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well as in the United States, with an estimated prevalence
of 1%–2%. The prevalence of HCV infection varies by geo-
graphical region [14,15], is higher among men than
women [16], and may be very high in special populations.
Population-based studies indicate that 40% of chronic
liver disease is HCV related [17]. People with severe men-
tal illness appear to have a higher risk of HCV for a variety
of reasons, including elevated rates of injection drug use,
multiple, high-risk sexual partners, infrequent use of con-
doms, a tendency to trade sex for material gain, and
engagement in sexual activity while using psychoactive
substances [18]. Several psychiatric disorders, including
schizophrenia, depressive disorders, psychosis, bipolar
disorder, anxiety disorders, were found more frequent
among HCV-infected veterans compared with those who
were not infected [19].
Klinkenberg et al [20] found a prevalence rate of 30%
among homeless persons with co-occurring severe mental
illness and substance use disorders. Serum anti-HCV anti-
bodies were detected in 6.7% in institutionalized psychi-
atric patients [21]. Psychiatric disorders were present in
60% of 206 consecutive patients with HCV infection
attending a Veteran Medical Center [22]. An American
multisite study of blood-borne infections among persons
with severe mental illness found a prevalence of hepatitis
C of 19.6 percent, 11 times the overall population rate
[23].
While little is known about hepatitis C outcome among
the severely mentally ill, it is likely to be worse because of
lack of access to and compliance with health care and fur-
ther worsened by hepatic damage due to substance use.
Moreover, since most psychotropic drugs are hepatically
metabolized, chronic hepatitis C may complicate phar-
macotherapy in this population. The high prevalence of
the virus in this population also places mental health care
workers at risk for infection, many of whom may be unfa-
miliar with universal precautions protocol [24]. All that
makes HCV infection a first rank problem in the manage-
ment of psychiatric patients.
The aims of the present naturalistic study were: 1) to
assess the prevalence of HCV infection in a population of
acute psychiatric in-patients; 2) to find out relationships
between HCV comorbidity and clinical features of psychi-
atric patients.
Methods
The study was carried out at a12 bed PICU of a general
hospital with a catchment area of about 210.000 inhabit-
ants. Admissions exclude persons under age 18. As the
hospital is in the center of Rome, near St. Peter's Basilica,
we also accept foreign patients with different back-
grounds. We do not think our population of patients to be
unique if compared to psychiatric patients in general. The
patients examined were all those discharged in a six-years
period. The following data were ascertained for each
patient: sex, age, diagnosis, commitment, length of hospi-
talization, psychopharmacological treatment on admis-
sion and on discharge. Final longitudinal best-estimate
diagnoses (DSM-IV-TR) were generated by consensus of
the authors. The authors have been cooperating in the
assessment of the patients admitted to the PICU in the last
ten years and have shown a high inter-rater reliability. In
as many patients as possible, as part of clinical routine, we
registered years of education, age at the onset of the disor-
der, history of suicide attempts, and assessed clinical con-
ditions by the Brief Psychiatric Rating Scale (BPRS),
including 24 items rated from 1 to 7, the Global Assess-
ment of Functioning (GAF) scale, and the Clinical Global
Impression (CGI). Social class was rated using an original
scale that considers the years of education and the
employment status of the patient and of the head of his/
her family, and the residence of the patient (1–5 point
scoring system for each item, range of total score: 5–25).
We used a modified version of the Morrison's scale [25] to
rate patients' highest level of hostile or violent behavior
during hospitalization. No distinction was made in the
analyses between alcohol/drug abuse or dependence. The
base number of patients for each rating scale is shown in
the freedom of degree of the statistics reported in Table n.
2. All patients were checked for HCV antibody. Patients
underwent laboratory routine in the early morning of the
first week-day after their admission. The interval between
patients' admission and laboratory routine may have been
>48 hours long (in the rare case of two consecutive holi-
day days). As a consequence, very few cases may have left
the hospital before undergoing laboratory routine. Diag-
nostic comparisons were between persons with the pri-
mary psychiatric diagnosis of schizophrenia,
schizoaffective disorder, bipolar disorder, unipolar
depression, and other diagnoses. Comparison were also
made between participants with and without a primary or
secondary diagnosis of substance-related disorder. The χ2
test was used to analyze categorical variables. T-test was
performed for continuous variables. Although many con-
sidered continuous variables are not really interval, we
chose to use T-test because of the high number of exam-
ined subjects. All p values were two tailed, and statistical
significance was set at p < 0.05. Logistic regression is the
statistical method of choice for analyzing the effects of
independent variables on a dichotomous dependent vari-
able. Multivariate logistic regression has been used to
investigate the effect of different risk factors such as any
substances abuse, previous suicides attempts, years of
education, Morrison Scale on the risk of infection with
hepatitis C.Clinical Practice and Epidemiology in Mental Health 2006, 2:26 http://www.cpementalhealth.com/content/2/1/26
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We collected all the data as part of our clinical routine.
Consensus was not asked to the patients for the use of the
anonymous epidemiological data. As the main purpose of
the study was descriptive in nature, we did not specify
hypotheses related to the study objectives in advance.
Results
In the considered period, 2396 cases, 1067 men (44.5%)
and 1329 women (55.5%) were admitted to the PICU.
Involuntary admissions were 604 (25.2%). Patients'
mean age was 41.9 (± 14.1) years, mean years of educa-
tion were 10.7 (± 3.9). Ethnic background was Caucasian
in 98% of cases. The most frequent psychiatric diagnoses
are shown in Table n. 1. Since many patients have been
admitted more than once in the period of study, with pos-
sible bias in the distribution of medical comorbidity, we
decided to examine only the first admission for each
patient in the considered period, although the observa-
tions in the following admissions could have been more
accurate. Overall, we found that, among the 2396 cases,
1492 patients have been admitted. Forty-two of them
(2.8%) were HCV seropositive. None of them had been
treated in the past or was treated with interferon at the
time of the study. Among the five major groups of primary
psychiatric diagnosis of the 1492 patients, the prevalence
of HCV infection was not significantly different: schizo-
phrenia (6/136, 4.4%), schizoaffective disorder (6/143,
4.2%), bipolar disorder (10/534, 1.9%), unipolar depres-
sion (1/89, 1.1%), other diagnoses (19/571, 3.3%) [χ2 =
5.282, fd = 4, p = .260]. Between patients with and with-
out HCV infection, there was no significant difference in
length of hospitalization, age at the onset of the disorder,
in the scores of current GAF, BPRS total, CGI (see Table n.
2), in the percentage of patients treated with antipsychot-
ics, benzodiazepines, valproate, lithium, and in the mean
dosage utilized (data not shown). HCV infection was
more frequent among patients who received a primary or
secondary diagnosis of any substance-related disorder,
alcohol-related disorder, cannabis-related disorder,
cocaine-related disorder, opioid-related disorder (see
Table n. 3). HCV infection tended to be more frequent in
men (25/653, 3.8%) than in women (17/839, 2.0%), but
the difference failed to reach the level of significance [χ2 =
3.726, fd = 1, p = .054]. Furthermore, patients with HCV
infection had less years of education, were of lower social
class, received lower last year best GAF and Morrison's
scale scores (see Table n. 2). HCV infection was more fre-
quent among the patients with a previous suicide attempt
(14/227, 6.2%) than among the patients without previ-
ous suicide attempt (12/639, 1.4%) [χ2 = 9.161; fd = 1;p =
.002]. Reliable history of previous suicide attempt was
unavailable for 625 (41.9%) patients, most of whom were
early transferred to other PICUs for overcrowding of our
PICU or for administrative reasons. The regression (Table
n. 4) shows a significant effect of previous suicide
attempts (p = 0.01; OR = 2.87) and substances abuse (p <<
0.05; OR = 5.31) on the risk of HCV infection. The associ-
ation with years of education is not significant (p > 0.05)
but there is an indication of a trend: patients who
attended high school has a lower risk (OR = 0.57) than
patients who attended only elementary school and the
Odds ratio is 0.34 for patients with university education.
The risk of having hepatitis C is 2.51 times higher in
patients with a score between 8 and 9 on the Morrison
Scale.
Table 1: Psychiatric diagnoses of the 1492 patients
Diagnosis N° of cases (%)
Schizophrenia 134 (9.0%)
Schizoaffective disorder 134 (9.0%)
Bipolar disorder mania 232 (15.6%)
Bipolar disorder depression 62 (4.2%)
Bipolar disorder mixed 214 (14.3%)
Unipolar depression 89 (6.0%)
Dysthymic disorder or depression NOS 45 (3.0%)
Psychotic disorder NOS 331 (22.2%)
Delusional disorder 14 (0.9%)
Obsessive-compulsive disorder 8 (0.6%)
Dissociative disorders 20 (1.3%)
Alcohol or Substance related disorder 26 (1.7%)
Personality disorder 35 (2.3%)
behavioral misconduct related with Mental retardation 36 (2.4%)
behavioral misconduct related with Dementia 9 (0.6%)
Delirium, Mood or Psychotic disorder due to general medical condition 16 (1.1%)
Asperger's disorder 5 (0.3%)
Eating disorders 5 (0.3%)
Other diagnoses 81 (5.4%)Clinical Practice and Epidemiology in Mental Health 2006, 2:26 http://www.cpementalhealth.com/content/2/1/26
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Discussion
The strengths of the study were its large sample size and
the high number of socio-demographic and clinical varia-
bles assessed in most patients. Despite these strengths, we
must acknowledge several significant limitations. First, as
in all non-epidemiological studies, the sample may not be
representative. Hospital-based samples are not represent-
ative of the spectrum of the disorder found in the general
population or in outpatient samples. Second, history of
previous suicide attempts was not available in nearly 40%
of the patients. However, we have no reason to suspect
that these patients were different from those whose his-
tory of previous suicide attempts was assessed. Actually,
we were not able to assess the history of previous suicide
attempts only in patients who were early transferred to
other PICUs for overcrowding of our PICU or for admin-
istrative reasons, i.e. not for clinical reasons. In the emer-
gency psychiatric setting, complete neuropsychiatric
assessment of all patients is almost impossible to achieve.
The percentage of patients whose history of previous sui-
cide attempts was not assessed was similar in the HCV
(16/42; 38.1%) and the non-HCV group (42.0%) [χ2 =
0.123; fd = 1;p = .726]. Third, because so many compari-
sons were made, significance might be reached by chance
in some cases. A cautious interpretation of the marginally
significant findings is suggested.
The high rate of HCV infection found in the present study
arises concern, especially considering the almost unavoid-
able chronic course of the infection and its serious conse-
quences. However, the rate is much lower in comparison
with the results of previous studies on psychiatric popula-
tion.
The lower prevalence of HCV infection in our study in
comparison with previous studies is probably due to two
factors. First, in the emergency psychiatric setting, the
HCV prevalence is likely to be lower in comparison with
that observed in chronic psychiatric patients. Among a
population of Spanish acute psychiatric in-patients, the
prevalence of HCV seropositivity was 5.1% [26], a result
similar to that observed in the present study. Second, the
number of patients with a primary diagnosis of substance-
related disorder was relatively low in our sample (52/
1492, 3.5%). In Italy, patients with a primary diagnosis of
substance-related disorder are treated in specific depart-
ments, and not in mental health departments. They are
seldom admitted to PICUs. As a consequence, almost only
patients with a secondary diagnosis of substance-related
disorder entered our study. Consistently with previous
studies, we noted a higher frequency of HCV infection in
men. However, the difference in gender prevalence failed
to reach the statistical significance. In the United States,
the rates of hepatitis C infection differ by gender: 2.5% for
men compared with 1.2% for women [27]. Among per-
sons with severe mental illness, hepatitis C rates are higher
and also differ by gender: 19.6% for men and 9.8% for
women [23].
Table 3: Categorical variables in patients with and without hcv infection
Variable HCV infection No HCV infection χ2 df P
Gender (M/F) 25 (59.5%)/17 (40.5%) 628 (43.3%)/822 (56.7%) 3.726 1 .054
Previous suicide attempt (Y/N) 14 (33.3%)/12 (28.6%) 213 (14.7%)/627 (43.2%) 9.161 1 .002*
Any alcohol or substance use disorder 27 (64.3%) 221 (15.2%) 67.348 1 .000*
Alcohol use disorder 13 (31.0%) 142 (9.8%) 17.423 1 .000*
Cannabis use disorder 6 (14.3%) 81 (5.6%) 4.153 1 .042*
Cocaine use disorder 7 (16.7%) 31 (2.1%) 29.106 1 .000*
Opioid use disorder 12 (28.6%) 18 (1.2%) 141.178 1 .000*
Table 2: Continuous variables in patients with and without hcv infection
Variable HCV infection No HCV infection T df P
Age (years) 38.6 (± 11.3) 42.1 (± 14.6) 1.515 1480 .130
Hospitalization length (days) 13.6 (± 12.0) 11.1 (± 12.7) -1.261 1476 .207
Education (years) 9.2 (± 2.8) 10.8 (± 4.0) 2.070 898 .039*
Social class 12.1 (± 3.4) 14.4 (± 4.3) 2.873 886 .004*
Current GAF 21.6 (± 4.9) 23.6 (± 7.6) 1.326 910 .185
Last year best GAF score 42.9 (± 15.1) 50.5 (± 15.1) 2.641 874 .008*
Age at the onset of the disorder 23.4 (± 13.4) 29.1 (± 13.5) 1.909 736 .057
BPRS total score 61.0 (± 14.9) 58.7 (± 13.3) -0.899 883 .369
Morrison 2.1 (± 2.8) 1.2 (± 1.9) -3.053 1470 .002*
CGI 5.8 (± 0.6) 5.7 (± 0.6) 0.945 996 .345
BPRS: Brief Psychiatric Rating Scale; GAF: Global Assessment of Functioning Scale; CGI: Clinical Global Impression.Clinical Practice and Epidemiology in Mental Health 2006, 2:26 http://www.cpementalhealth.com/content/2/1/26
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Our results are consistent with the study of Dinwiddie et
al. [24] who found that patients positive for hepatitis C
virus were more likely to be male, slightly less well edu-
cated, and to have a psychoactive substance use disorder
diagnosis but no other psychiatric diagnosis. Differently
from our study but in accordance with the study of Osher
et al [28], they also found that HCV patients were slightly
older than the comparison group. However, Osher et al
[28] hypothesized that age might not be a risk factor in
and of itself but may reflect a complicated cohort effect
involving the Vietnam War era. HCV is transmitted prima-
rily through direct percutaneous exposure to blood. Blood
transfusion accounted for a substantial proportion of
HCV infections before 1990, when routine test began, but
now accounts for only a small percentage [17]. Although
the main route of transmission is via contaminated blood,
in up to 50% of the cases no recognizable transmission
factor/route can be identified [15]. While, it is not possi-
ble to ascertain the causes of such a high rate, it is tempt-
ing to hypothesize that promiscuous and unsafe sexual
behavior associated with severe psychiatric illness may be
implied as significant risk factor. However, the role of sex-
ual behavior as a risk factor for HCV transmission is still
unclear. In a multisite study of blood-borne infections
among persons with severe mental illness, the rate of hep-
atitis C was higher for men at each of the five sites of the
study ranging from 7.9% to 35.5%, compared with 4.9%
to 16.9% for women [29]. In the same study, sexual risks
did not appear to play a major role in hepatitis C trans-
mission since women had significantly more lifetime
unprotected sex risks, including vaginal sex, anal sex, sex
in exchange for drugs, and sex in exchange for money or
gifts. The rate of sexual transmission of hepatitis C virus
was found low also in the studies of Tor et al [30] and Fis-
cus et al [31]. On the other hand, the results of other stud-
ies support a more prominent role of sexual transmission
of hepatitis C [32-37].
In accordance with previous studies, we found HCV infec-
tion related with the diagnoses of any substance-related
disorder, alcohol-related disorder, cannabis-related disor-
der, cocaine-related disorder, opioid-related disorder. The
logistic regression confirmed the independent association
between any substance-related disorder and HCV infec-
tion with a large effect size. While it is easy to attribute the
higher prevalence of HCV infection among patients with
a opioid-related disorder to their frequent habit of using
non sterile needles, it is less clear why the HCV infection
is also more prevalent among patients who use only oral
or inhalant drugs. HCV prevalence as high as 46% has
been found in populations with alcoholic liver disease,
even when subject with intravenous drug use and with
history of blood transfusion were excluded [38]. Also
among alcoholics without liver disease the hepatitis C rate
(4.8%) is higher than that in the general population [39]
and even tobacco use has been found correlated with the
susceptibility to HCV infection [40]. Risky behavior or
unknown biological factors associated with substance-
related disorder may account for the higher risk of HCV
infection in these patients.
Unexpectedly, we found a higher rate of HCV infection
among patients with a history of suicide attempt. The
logistic regression confirmed the independent association
between history of previous suicide attempt and HCV
infection. This is the original and major result of the
present study which has never been reported before,
although depressive symptoms are very frequent during
both the acute and chronic stages of hepatitis C [41], and
suicidal behavior has been repeatedly reported in patients
affected by HCV infection [42]. The result is not easy to
explain. Two hypotheses are offered. First, specific treat-
ment of HCV infection, inducing or worsening a depres-
sive state, might have precipitated suicidal behavior.
Several reports described suicides or suicide attempts in
the course of interferon treatment [43-49]. However, as
already noted, no patient had been treated with inter-
feron. Second, HCV infection may be associated with
severer forms of psychiatric disorders which carry a higher
risk of suicide. The last hypothesis was supported by the
findings of worse global functioning in the last year and
Table 4: Logistic regression
Independent variables z p OR Confidential interval 95%
Previous suicide attempt 2,47 0,01* 2,87 1.24 – 6,61
Substance abuse 3,92 0,0001* 5,31 2,31 – 12,22
Scolarity (High school) -1,24 0,21 0,57 0,23 – 1,39
Scolarity (University years) -1,37 0,16 0,34 0,08 – 1,57
Morrison scale (1–7) 0,39 0,69 1,19 0,50 – 2,84
Morrison scale (8–9) -9,5 0,26 2,51 0,49 – 12,82Clinical Practice and Epidemiology in Mental Health 2006, 2:26 http://www.cpementalhealth.com/content/2/1/26
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more hostile or violent behavior during the hospitaliza-
tion in patients with HCV infection.
Abbreviations
HCV = Hepatitis C Virus; PICU = Psychiatric Intensive
Care Unit; NOS not otherwise specified; BPRS = Brief Psy-
chiatric Rating Scale; GAF = Global Assessment of Func-
tioning; CGI = Clinical Global Impression.
References
1. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP: Medical comorbidity
in schizophrenia.  Schizophr Bull 1996, 22:413-430.
2. Hewer W, Rossler W: Mortality of patients with functional psy-
chiatric illnesses during inpatient treatment.  Fortschr Neurol
Psychiatr 1997, 65:171-181.
3. Zubenko GS, Marino LJ Jr, Sweet RA, Rifai AH, Mulsant BH, Pasternak
RE: Medical comorbidity in elderly psychiatric inpatients.  Biol
Psychiatry 1997, 41:724-736.
4. Reeves RR, Torres RA: Exacerbation of psychosis by misinter-
pretation of physical symptoms.  South Med J 2003, 96:702-704.
5. Farmer S: Medical problems of chronic psychiatric patients in
a community support program.  Hosp Comm Psychiatry 1987,
38:745-749.
6. Woo BK, Daly JW, Allen EC, Jeste DV, Sewell DD: Unrecognized
medical disorders in older psychiatric inpatients in a senior
behavioral health unit in a university hospital.  J Geriatr Psychia-
try Neurol 2003, 16:121-125.
7. Black DW: Iowa record-linkage study: death rates in psychiat-
ric patients.  J Affect Disord 1998, 50:277-282.
8. Dembling B: Mental disorder as a contributing cause of death
in the U.S. in 1992.  Psychiatr Serv 1997, 48:45.
9. Dembling BP, Chen DT, Vachon L: Life expectancy and causes of
death in a population treated for serious mental illness.  Psy-
chiatr Serv 1999, 50:1036-1042.
10. Felker B, Yazel JJ, Short D: Mortality and medical comorbidity
among psychiatric patients: a review.  Psychiatr Serv 1996,
47:1356-1363.
11. Harris EC, Barrablough B: Excess mortality of mental disorder.
Br J Psychiatry 1998, 173:11-53.
12. Stroup TS, Gilmore JH, Jarskog LF: Management of medical ill-
nesses in persons with schizophrenia.  Psychiatr Ann 2000,
30:35-40.
13. Rosenberg SD, Swanson JW, Wolford GL, Osher FC, Swartz MS,
Essock SM, Butterfield MI, Marsh BJ, Five-Site Health and Risk Study
Research Committee: The five-site health and risk study of
blood-borne infections among persons with severe mental
illness.  Psychiatr Serv 2003, 54:827-835.
14. Desenclos JC: Epidemiology of hepatitis C.  Rev Prat 2000,
50:1066-1070.
15. Memon MI, Memon MA: Hepatitis C: an epidemiological
review.  J Viral Hepat 2002, 9:84-100.
16. Balogun MA, Ramsay ME, Hesketh LM, Andrews N, Osborne KP, Gay
NJ, Morgan-Cap P: The prevalence of hepatitis C in England
and Wales.  J Infect 2002, 45:219-226.
17. Williams I: Epidemiology of hepatitis C in the United States.
Am J Med 1999, 107(6B):2S-9S.
18. Davidson S, Judd F, Folley D, Hocking B, Thompson S, Hyland B: Risk
factors for HIV/AIDS and hepatitis C among the chronic
mentally ill.  Aust N Z J Psychiatry 2001, 35:203-209.
19. El-Serag HB, Kunik M, Richardson P, Rabeneck L: Psychiatric disor-
ders among veterans with hepatitis C infection.  Gastroenterol-
ogy 2002, 123:476-482.
20. Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S,
Ketema F, Constantine NT: Prevalence of human immunodefi-
ciency virus, hepatitis B, and hepatitis C among homeless
persons with co-occurring severe mental illness and sub-
stance use disorders.  Compr Psychiatry 2003, 44:293-302.
21. Cividini A, Pistorio A, Regazzetti A, Cerino A, Tinelli C, Mancuso A,
Ribola M, Galli ML, Agnusdei A, Leone M, Silini E, Mondelli MU: Hep-
atitis C virus infection among institutionalised psychiatric
patients: a regression analysis of indicators of risk.  J Hepatol
1997, 27:455-463.
22. Nguyen HA, Miller AI, Dieperink E, Willenbring ML, Tetrick LL, Dur-
fee JM, Ewing SL, Ho SB: Spectrum of disease in U.S. veteran
patients with hepatitis C.  Am J Gastroenterology 2002,
97:1813-1820.
23. Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, But-
terfield MI, Constantine NT, Wolford GL, Salyers MP: Prevalence
of HIV, hepatitis B, and hepatitis C in people with severe
mental illness.  Am J Public Health 2001, 91:31-37.
24. Dinwiddie SH, Shicker L, Newman T: Prevalence of hepatitis C
among psychiatric patients in the public sector.  Am J Psychiatry
2003, 160:172-174.
25. Morrison EF: A hierarchy of aggressive and violent behaviors
among psychiatric inpatients.  Hosp Commun Psychiatry 1992,
43:505-506.
26. Fernandez-Egea E, Gomez Gil E, Corbella Santoma B, Salamero Baro
M, Blanch Andreu J, Vades Miyar M: Serological testing and prev-
alence of human immunodeficiency, hepatitis B and C
viruses infections among acute psychiatric inpatients.  Med
Clin (Barc) 2002, 119:690-692.
27. Alter MJ, Kruszon-Moran D, Nainan OV, Mc Quillan GM, Gao F,
Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis
C virus infection in the United States, 1988 through 1994.  N
Eng J Med 1999, 341:556-562.
28. Osher FC, Goldberg RW, McNary SW, Swartz MS, Essock SM, But-
terfield MI, Rosenberg SD, the Five-Site Health and Risk Study
Research Committee: Substance abuse and the transmission of
hepatitis C among persons with severe mental illness.  Psychi-
atr Serv 2003, 54:842-847.
29. Butterfield MI, Bosworth HB, Meador KG, Stechuchak KM, Essock
SM, Osher FC, Goodman LA, Swanson JW, Bastian LA, Horner RD,
Five-Site Health and Risk Study Research Committee: Gender dif-
ferences in hepatitis C infection and risks among persons
with severe mental illness.  Psychiatr Serv 2003, 54:848-853.
30. Tor J, Llibre JM, Carbonell M, Muga R, Ribera A, Soriano V, Clotet B,
Sabria M, Foz M: Sexual transmission of hepatitis C virus and
its relation with hepatitis B virus and HIV.  Br Med J 1990,
301:1130-1133.
31. Fiscus SA, Kelly WF, Battigelli DA, Weber DJ, Schoenbach VJ, Landis
SE, Wilber JC, Van der Host CM: Hepatitis C virus seropreva-
lence in clients of sexually transmitted disease clinics in
North Carolina.  Sex Transm Dis 1994, 21:155-160.
32. Cilla G, Perez-Trallero E, Iturriza M, Arrizabalaga J, Iribarren JA: Pos-
sibility of heterosexual transmission of hepatitis C virus.  Eur
J Microbiol Infect Dis 1991, 10:533-534.
33. Salvaggio A, Conti M, Albano A, Pianetti A, Muggiasca ML, Re M, Sel-
vaggio L: Sexual transmission of hepatitis C virus and HIV-1
infection in intravenous drug users.  Eur J Epidemiology 1993,
9:279-284.
34. Sladden TJ, Hickey AR, Dunn TM, Beard Jr: Hepatitis C transmis-
sion on the north coast of New South Wales: explaining the
unexplained.  Med J Australia 1997, 166:290-293.
35. Centers for Disease Control and Prevention: Recommendations
for prevention and control of hepatitis C virus (HCV) infec-
tion and HCV-related chronic disease.  Morbidity and Mortality
Weekly Report 1998, 47(RR-19):1-39.
36. Hershow RC, Kalish LA, Sha B, Till M, Cohen M: Hepatitis C virus
infection in Chicago women with or at risk for HIV infection.
Sex Transm Dis 1998, 25:527-532.
37. Ward H, Pallecaros A, Green A, Day S: Health issues associated
with increasing use of "crack" cocaine among female sex
workers in London.  Sex Transm Infect 2000, 76:292-293.
38. Marsano LS, Pena LR: The interaction of alcoholic liver disease
and hepatitis C.  Hepatogastroenterology 1998, 45:331-339.
39. Corrao G, Carle F, Lepore AR, Zepponi E, Galatola G, Di Orio F:
Interaction between alcohol consumption and positivity for
antibodies to hepatitis C virus on the risk of liver cirrhosis: a
case-controlled study.  Eur J Epidemiol 1992, 9:634-639.
40. Stuyt EB: Hepatitis C in patients with co-occurring mental dis-
orders and substance use disorders: is tobacco use a possible
risk factor?  Am J Addiction 2004, 13:46-52.
41. Dieperink E, Willenbring M, Ho SB: Neuropsychiatric symptoms
associated with hepatitis C and interferon alpha: a review.
Am J Psychiatry 2000, 157:867-876.
42. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N:
Assessment of long term outcomes of community-acquiredPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Clinical Practice and Epidemiology in Mental Health 2006, 2:26 http://www.cpementalhealth.com/content/2/1/26
Page 7 of 7
(page number not for citation purposes)
hepatitis C infection in a cohort with sera stored from 1971
to 1975.  Hepatology 2000, 32:582-587.
43. Janssen HL, Brouwer JT, van der Mast RC, Schalm SW: Suicide asso-
ciated with alfa-interferon therapy for chronic hepatitis.  J
Hepatol 1994, 21:241-243.
44. Bourat L, Larrey D, Michel H: Attempted suicide during treat-
ment of chronic viral hepatitis C with interferon. Apropos of
2 cases.  Gastroenterol Clin Biol 1995, 19:1063.
45. Rifflet H, Vuillemin E, Oberti F, Duverger P, Laine P, Garre JB, Cales
P: Suicidal impulses in patients with chronic viral hepatitis C
during or after therapy with interferon alpha.  Gastroenterol Clin
Biol 1998, 22:353-357.
46. Fukunishi K, Tanaka H, Maruyama J, Takahashi H, Kitagishi H,
Ueshima T, Maruyama K, Sakata I: Burns in a suicide attempt
related to psychiatric side effects of interferon.  Burns 1998,
24:581-583.
47. Pardelli R, Vivaldi I, Maccanti O, Sani S, Menicagli V: Attempted sui-
cide during interferon therapy: a case report and literature
review.  Infez Med 1998, 6:221-224.
48. Windemuth D, Bacharach-Buhles M, Hoffman K, Altmeyer P:
Depression and suicidal intentions as a side effect of high dos-
age of interferon-alpha therapy: two cases.  Hautarzt 1999,
50:266-269.
49. Kovacs A, Szomor A, Abraham I, Nagy F, Losonczy H: Orv Hetil 2002,
143:2183-2187.